image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC2391084_f3_22974.jpg | What object or scene is depicted here? | Enhanced green fluorescent protein expression during retinal development in Tg(ccnb1:EGFP)nt18 zebrafish. Enhanced green fluorescent protein (EGFP; A-D), proliferating cell nuclear antigen (PCNA; E-H), and merged expression patterns (I-L) are shown at 36, 48, 72 hpf, and 5 dpf of retinal development. At 36 hpf, PCNA an... |
PMC2391084_f3_22970.jpg | What does this image primarily show? | Enhanced green fluorescent protein expression during retinal development in Tg(ccnb1:EGFP)nt18 zebrafish. Enhanced green fluorescent protein (EGFP; A-D), proliferating cell nuclear antigen (PCNA; E-H), and merged expression patterns (I-L) are shown at 36, 48, 72 hpf, and 5 dpf of retinal development. At 36 hpf, PCNA an... |
PMC2391084_f3_22975.jpg | What key item or scene is captured in this photo? | Enhanced green fluorescent protein expression during retinal development in Tg(ccnb1:EGFP)nt18 zebrafish. Enhanced green fluorescent protein (EGFP; A-D), proliferating cell nuclear antigen (PCNA; E-H), and merged expression patterns (I-L) are shown at 36, 48, 72 hpf, and 5 dpf of retinal development. At 36 hpf, PCNA an... |
PMC2391084_f3_22973.jpg | Describe the main subject of this image. | Enhanced green fluorescent protein expression during retinal development in Tg(ccnb1:EGFP)nt18 zebrafish. Enhanced green fluorescent protein (EGFP; A-D), proliferating cell nuclear antigen (PCNA; E-H), and merged expression patterns (I-L) are shown at 36, 48, 72 hpf, and 5 dpf of retinal development. At 36 hpf, PCNA an... |
PMC2391084_f3_22979.jpg | What object or scene is depicted here? | Enhanced green fluorescent protein expression during retinal development in Tg(ccnb1:EGFP)nt18 zebrafish. Enhanced green fluorescent protein (EGFP; A-D), proliferating cell nuclear antigen (PCNA; E-H), and merged expression patterns (I-L) are shown at 36, 48, 72 hpf, and 5 dpf of retinal development. At 36 hpf, PCNA an... |
PMC2391084_f3_22980.jpg | What is the focal point of this photograph? | Enhanced green fluorescent protein expression during retinal development in Tg(ccnb1:EGFP)nt18 zebrafish. Enhanced green fluorescent protein (EGFP; A-D), proliferating cell nuclear antigen (PCNA; E-H), and merged expression patterns (I-L) are shown at 36, 48, 72 hpf, and 5 dpf of retinal development. At 36 hpf, PCNA an... |
PMC2391084_f3_22969.jpg | What is the focal point of this photograph? | Enhanced green fluorescent protein expression during retinal development in Tg(ccnb1:EGFP)nt18 zebrafish. Enhanced green fluorescent protein (EGFP; A-D), proliferating cell nuclear antigen (PCNA; E-H), and merged expression patterns (I-L) are shown at 36, 48, 72 hpf, and 5 dpf of retinal development. At 36 hpf, PCNA an... |
PMC2391084_f4_22998.jpg | What object or scene is depicted here? | Enhanced green fluorescent protein expression in the Tg(ccnb1:EGFP)nt18 adult zebrafish retina. Enhanced green fluorescent protein (EGFP; C, F, I, J, M), proliferating cell nuclear antigen (PCNA; B, H, K), Pax6 (E), glutamine synthetase (GS; N), and merged expression (A, D, G, L, O) are shown. EGFP and PCNA are strongl... |
PMC2391084_f4_23000.jpg | Describe the main subject of this image. | Enhanced green fluorescent protein expression in the Tg(ccnb1:EGFP)nt18 adult zebrafish retina. Enhanced green fluorescent protein (EGFP; C, F, I, J, M), proliferating cell nuclear antigen (PCNA; B, H, K), Pax6 (E), glutamine synthetase (GS; N), and merged expression (A, D, G, L, O) are shown. EGFP and PCNA are strongl... |
PMC2391084_f4_22997.jpg | What can you see in this picture? | Enhanced green fluorescent protein expression in the Tg(ccnb1:EGFP)nt18 adult zebrafish retina. Enhanced green fluorescent protein (EGFP; C, F, I, J, M), proliferating cell nuclear antigen (PCNA; B, H, K), Pax6 (E), glutamine synthetase (GS; N), and merged expression (A, D, G, L, O) are shown. EGFP and PCNA are strongl... |
PMC2391084_f5_23008.jpg | What is the core subject represented in this visual? | Enhanced green fluorescent protein expression in the light-damaged Tg(ccnb1:EGFP)nt18 zebrafish retina. To initiate the regeneration response, dark-adapted adult Tg(ccnb1:EGFP)nt18 zebrafish were exposed to constant, high-intensity light to induce photoreceptor apoptosis. At 48 h of constant light exposure, enhanced gr... |
PMC2391084_f5_23009.jpg | What is the core subject represented in this visual? | Enhanced green fluorescent protein expression in the light-damaged Tg(ccnb1:EGFP)nt18 zebrafish retina. To initiate the regeneration response, dark-adapted adult Tg(ccnb1:EGFP)nt18 zebrafish were exposed to constant, high-intensity light to induce photoreceptor apoptosis. At 48 h of constant light exposure, enhanced gr... |
PMC2391084_f5_23012.jpg | What is the dominant medical problem in this image? | Enhanced green fluorescent protein expression in the light-damaged Tg(ccnb1:EGFP)nt18 zebrafish retina. To initiate the regeneration response, dark-adapted adult Tg(ccnb1:EGFP)nt18 zebrafish were exposed to constant, high-intensity light to induce photoreceptor apoptosis. At 48 h of constant light exposure, enhanced gr... |
PMC2391084_f6_22995.jpg | What is the dominant medical problem in this image? | Enhanced green fluorescent protein expression during retinal development in Tg(1016α1tubulin:EGFP) zebrafish. Enhanced green fluorescent protein (EGFP; B, E, H), proliferating cell nuclear antigen (PCNA; C, F, I), and merged expression patterns (A, D, G) are shown at 54 hpf, 72 hpf, and 96 hpf of retinal development. A... |
PMC2391084_f6_22989.jpg | What is the central feature of this picture? | Enhanced green fluorescent protein expression during retinal development in Tg(1016α1tubulin:EGFP) zebrafish. Enhanced green fluorescent protein (EGFP; B, E, H), proliferating cell nuclear antigen (PCNA; C, F, I), and merged expression patterns (A, D, G) are shown at 54 hpf, 72 hpf, and 96 hpf of retinal development. A... |
PMC2391084_f6_22988.jpg | What stands out most in this visual? | Enhanced green fluorescent protein expression during retinal development in Tg(1016α1tubulin:EGFP) zebrafish. Enhanced green fluorescent protein (EGFP; B, E, H), proliferating cell nuclear antigen (PCNA; C, F, I), and merged expression patterns (A, D, G) are shown at 54 hpf, 72 hpf, and 96 hpf of retinal development. A... |
PMC2391084_f6_22992.jpg | What is the core subject represented in this visual? | Enhanced green fluorescent protein expression during retinal development in Tg(1016α1tubulin:EGFP) zebrafish. Enhanced green fluorescent protein (EGFP; B, E, H), proliferating cell nuclear antigen (PCNA; C, F, I), and merged expression patterns (A, D, G) are shown at 54 hpf, 72 hpf, and 96 hpf of retinal development. A... |
PMC2391084_f6_22993.jpg | What's the most prominent thing you notice in this picture? | Enhanced green fluorescent protein expression during retinal development in Tg(1016α1tubulin:EGFP) zebrafish. Enhanced green fluorescent protein (EGFP; B, E, H), proliferating cell nuclear antigen (PCNA; C, F, I), and merged expression patterns (A, D, G) are shown at 54 hpf, 72 hpf, and 96 hpf of retinal development. A... |
PMC2391084_f6_22991.jpg | What key item or scene is captured in this photo? | Enhanced green fluorescent protein expression during retinal development in Tg(1016α1tubulin:EGFP) zebrafish. Enhanced green fluorescent protein (EGFP; B, E, H), proliferating cell nuclear antigen (PCNA; C, F, I), and merged expression patterns (A, D, G) are shown at 54 hpf, 72 hpf, and 96 hpf of retinal development. A... |
PMC2391084_f6_22994.jpg | What can you see in this picture? | Enhanced green fluorescent protein expression during retinal development in Tg(1016α1tubulin:EGFP) zebrafish. Enhanced green fluorescent protein (EGFP; B, E, H), proliferating cell nuclear antigen (PCNA; C, F, I), and merged expression patterns (A, D, G) are shown at 54 hpf, 72 hpf, and 96 hpf of retinal development. A... |
PMC2391084_f6_22987.jpg | What is the core subject represented in this visual? | Enhanced green fluorescent protein expression during retinal development in Tg(1016α1tubulin:EGFP) zebrafish. Enhanced green fluorescent protein (EGFP; B, E, H), proliferating cell nuclear antigen (PCNA; C, F, I), and merged expression patterns (A, D, G) are shown at 54 hpf, 72 hpf, and 96 hpf of retinal development. A... |
PMC2391084_f7_22985.jpg | Describe the main subject of this image. | Enhanced green fluorescent protein and proliferating cell nuclear antigen expression in Tg(1016α1tubulin:EGFP) and Tg(ccnb1:EGFP)nt18 72 hpf larva head sections. Enhanced green fluorescent protein (EGFP; C, F), proliferating cell nuclear antigen (PCNA; B, E), and merged expression patterns (A, D) are shown in 72 hpf la... |
PMC2391084_f7_22983.jpg | What is the core subject represented in this visual? | Enhanced green fluorescent protein and proliferating cell nuclear antigen expression in Tg(1016α1tubulin:EGFP) and Tg(ccnb1:EGFP)nt18 72 hpf larva head sections. Enhanced green fluorescent protein (EGFP; C, F), proliferating cell nuclear antigen (PCNA; B, E), and merged expression patterns (A, D) are shown in 72 hpf la... |
PMC2391084_f7_22981.jpg | What is shown in this image? | Enhanced green fluorescent protein and proliferating cell nuclear antigen expression in Tg(1016α1tubulin:EGFP) and Tg(ccnb1:EGFP)nt18 72 hpf larva head sections. Enhanced green fluorescent protein (EGFP; C, F), proliferating cell nuclear antigen (PCNA; B, E), and merged expression patterns (A, D) are shown in 72 hpf la... |
PMC2391084_f7_22986.jpg | What can you see in this picture? | Enhanced green fluorescent protein and proliferating cell nuclear antigen expression in Tg(1016α1tubulin:EGFP) and Tg(ccnb1:EGFP)nt18 72 hpf larva head sections. Enhanced green fluorescent protein (EGFP; C, F), proliferating cell nuclear antigen (PCNA; B, E), and merged expression patterns (A, D) are shown in 72 hpf la... |
PMC2391084_f7_22984.jpg | What is shown in this image? | Enhanced green fluorescent protein and proliferating cell nuclear antigen expression in Tg(1016α1tubulin:EGFP) and Tg(ccnb1:EGFP)nt18 72 hpf larva head sections. Enhanced green fluorescent protein (EGFP; C, F), proliferating cell nuclear antigen (PCNA; B, E), and merged expression patterns (A, D) are shown in 72 hpf la... |
PMC2391084_f7_22982.jpg | Describe the main subject of this image. | Enhanced green fluorescent protein and proliferating cell nuclear antigen expression in Tg(1016α1tubulin:EGFP) and Tg(ccnb1:EGFP)nt18 72 hpf larva head sections. Enhanced green fluorescent protein (EGFP; C, F), proliferating cell nuclear antigen (PCNA; B, E), and merged expression patterns (A, D) are shown in 72 hpf la... |
PMC2391106_fig1_23017.jpg | Describe the main subject of this image. | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391106_fig1_23023.jpg | What is the focal point of this photograph? | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391106_fig1_23021.jpg | What stands out most in this visual? | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391106_fig1_23019.jpg | What does this image primarily show? | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391106_fig1_23020.jpg | What is shown in this image? | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391106_fig1_23029.jpg | What is being portrayed in this visual content? | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391106_fig1_23025.jpg | What object or scene is depicted here? | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391106_fig1_23024.jpg | Describe the main subject of this image. | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391106_fig1_23016.jpg | What can you see in this picture? | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391106_fig1_23026.jpg | What is the dominant medical problem in this image? | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391106_fig1_23027.jpg | What is shown in this image? | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391106_fig1_23028.jpg | What is the main focus of this visual representation? | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391106_fig1_23015.jpg | What stands out most in this visual? | A representative immunohistochemical analysis of NGAL during the pathogenesis of the pancreatic gland. Representative sections of formalin-fixed, paraffin-embedded tissues immunolabelled with polyclonal anti-NGAL antibody using the horseradish peroxidase detection method with DAB substrate. Brown-coloured product indic... |
PMC2391120_fig1_23032.jpg | Can you identify the primary element in this image? | (A) Semiquantitative western blot assessment score – strength of band staining in relation to control sample – example with the monoclonal 8G7 clone MUC4 antibody (1 : 1000 dilution) on breast milk control (1 : 100 dilution) and four different bile samples (1 : 2 dilutions) (on 2% agarose (0.1% SDS) gel and 10 mM DTT).... |
PMC2391120_fig1_23033.jpg | What is the core subject represented in this visual? | (A) Semiquantitative western blot assessment score – strength of band staining in relation to control sample – example with the monoclonal 8G7 clone MUC4 antibody (1 : 1000 dilution) on breast milk control (1 : 100 dilution) and four different bile samples (1 : 2 dilutions) (on 2% agarose (0.1% SDS) gel and 10 mM DTT).... |
PMC2391121_fig6_23036.jpg | Describe the main subject of this image. | Representative images of immunohistochemistry of mouse CD31 and human VEGF in HT-29 xenografts in vehicle-treated mice (control group) (A and B, respectively), in CPT-11 100 mg kg−1 i.p. every week (MTD schedule) group of mice (C and D, respectively), in metronomic CPT-11 4 mg kg−1 i.p. daily group (E and F, respective... |
PMC2391121_fig6_23038.jpg | What can you see in this picture? | Representative images of immunohistochemistry of mouse CD31 and human VEGF in HT-29 xenografts in vehicle-treated mice (control group) (A and B, respectively), in CPT-11 100 mg kg−1 i.p. every week (MTD schedule) group of mice (C and D, respectively), in metronomic CPT-11 4 mg kg−1 i.p. daily group (E and F, respective... |
PMC2391121_fig6_23035.jpg | Describe the main subject of this image. | Representative images of immunohistochemistry of mouse CD31 and human VEGF in HT-29 xenografts in vehicle-treated mice (control group) (A and B, respectively), in CPT-11 100 mg kg−1 i.p. every week (MTD schedule) group of mice (C and D, respectively), in metronomic CPT-11 4 mg kg−1 i.p. daily group (E and F, respective... |
PMC2391121_fig6_23040.jpg | What stands out most in this visual? | Representative images of immunohistochemistry of mouse CD31 and human VEGF in HT-29 xenografts in vehicle-treated mice (control group) (A and B, respectively), in CPT-11 100 mg kg−1 i.p. every week (MTD schedule) group of mice (C and D, respectively), in metronomic CPT-11 4 mg kg−1 i.p. daily group (E and F, respective... |
PMC2391121_fig6_23042.jpg | What is the focal point of this photograph? | Representative images of immunohistochemistry of mouse CD31 and human VEGF in HT-29 xenografts in vehicle-treated mice (control group) (A and B, respectively), in CPT-11 100 mg kg−1 i.p. every week (MTD schedule) group of mice (C and D, respectively), in metronomic CPT-11 4 mg kg−1 i.p. daily group (E and F, respective... |
PMC2391121_fig6_23039.jpg | What's the most prominent thing you notice in this picture? | Representative images of immunohistochemistry of mouse CD31 and human VEGF in HT-29 xenografts in vehicle-treated mice (control group) (A and B, respectively), in CPT-11 100 mg kg−1 i.p. every week (MTD schedule) group of mice (C and D, respectively), in metronomic CPT-11 4 mg kg−1 i.p. daily group (E and F, respective... |
PMC2391128_fig1_23043.jpg | What is the central feature of this picture? | A liver metastasis from a gastric GIST before (A) and 1 week after (B) commencing imatinib therapy. FDG PET/CT scans, unenhanced CT (left), fused FDG PET and CT (right). Although there has been no morphological change in the metastasis, the abnormal baseline metabolic activity (colour scale) has rapidly resolved indica... |
PMC2391128_fig1_23046.jpg | What is the dominant medical problem in this image? | A liver metastasis from a gastric GIST before (A) and 1 week after (B) commencing imatinib therapy. FDG PET/CT scans, unenhanced CT (left), fused FDG PET and CT (right). Although there has been no morphological change in the metastasis, the abnormal baseline metabolic activity (colour scale) has rapidly resolved indica... |
PMC2391128_fig1_23044.jpg | What key item or scene is captured in this photo? | A liver metastasis from a gastric GIST before (A) and 1 week after (B) commencing imatinib therapy. FDG PET/CT scans, unenhanced CT (left), fused FDG PET and CT (right). Although there has been no morphological change in the metastasis, the abnormal baseline metabolic activity (colour scale) has rapidly resolved indica... |
PMC2391128_fig1_23045.jpg | What can you see in this picture? | A liver metastasis from a gastric GIST before (A) and 1 week after (B) commencing imatinib therapy. FDG PET/CT scans, unenhanced CT (left), fused FDG PET and CT (right). Although there has been no morphological change in the metastasis, the abnormal baseline metabolic activity (colour scale) has rapidly resolved indica... |
PMC2391148_F2_23048.jpg | What is the central feature of this picture? | Axial MRI images. A) Basal (pre-stroke): bilateral hyperintense lesions in white matter, predominantly in posterior regions in T2 weighted (1 y 2) and diffusion (3) sequences. B) Post-stroke: hyperintense signal in FLAIR (1), T2 (2) and diffusion (3) sequences localized in the right temporal cortex and subcortical area... |
PMC2391148_F2_23052.jpg | Can you identify the primary element in this image? | Axial MRI images. A) Basal (pre-stroke): bilateral hyperintense lesions in white matter, predominantly in posterior regions in T2 weighted (1 y 2) and diffusion (3) sequences. B) Post-stroke: hyperintense signal in FLAIR (1), T2 (2) and diffusion (3) sequences localized in the right temporal cortex and subcortical area... |
PMC2391148_F2_23049.jpg | What is the dominant medical problem in this image? | Axial MRI images. A) Basal (pre-stroke): bilateral hyperintense lesions in white matter, predominantly in posterior regions in T2 weighted (1 y 2) and diffusion (3) sequences. B) Post-stroke: hyperintense signal in FLAIR (1), T2 (2) and diffusion (3) sequences localized in the right temporal cortex and subcortical area... |
PMC2391148_F2_23051.jpg | What is the dominant medical problem in this image? | Axial MRI images. A) Basal (pre-stroke): bilateral hyperintense lesions in white matter, predominantly in posterior regions in T2 weighted (1 y 2) and diffusion (3) sequences. B) Post-stroke: hyperintense signal in FLAIR (1), T2 (2) and diffusion (3) sequences localized in the right temporal cortex and subcortical area... |
PMC2391148_F2_23050.jpg | What stands out most in this visual? | Axial MRI images. A) Basal (pre-stroke): bilateral hyperintense lesions in white matter, predominantly in posterior regions in T2 weighted (1 y 2) and diffusion (3) sequences. B) Post-stroke: hyperintense signal in FLAIR (1), T2 (2) and diffusion (3) sequences localized in the right temporal cortex and subcortical area... |
PMC2391148_F2_23047.jpg | What is the core subject represented in this visual? | Axial MRI images. A) Basal (pre-stroke): bilateral hyperintense lesions in white matter, predominantly in posterior regions in T2 weighted (1 y 2) and diffusion (3) sequences. B) Post-stroke: hyperintense signal in FLAIR (1), T2 (2) and diffusion (3) sequences localized in the right temporal cortex and subcortical area... |
PMC2391150_F1_23055.jpg | What is the dominant medical problem in this image? | Sagittal view of a computed tomography scan of the dorsal spine showing the hematoma in the extradural space (arrow) compressing the cord and displacing the spinous process. |
PMC2391150_F1_23054.jpg | What's the most prominent thing you notice in this picture? | Sagittal view of a computed tomography scan of the dorsal spine showing the hematoma in the extradural space (arrow) compressing the cord and displacing the spinous process. |
PMC2391151_F1_23053.jpg | What stands out most in this visual? | Magnetic resonance imaging of the head. Hyperintense basal ganglia lesions on T2-weighted images. |
PMC2391152_F2_23060.jpg | What stands out most in this visual? | dAux mutations disrupt the proneural enhancement and the lateral inhibition during R8 specification. Projected spinning disk confocal micrographs of Act5C>FLP/+; FRT5-5Z3515, dAuxF956*/FRT5-5Z3515, ubi-GFPnls larval eye stained for Atonal (A-D, red) and Senseless (E-H, red). Regions marked with boxes in (C) and (G) are... |
PMC2391152_F2_23062.jpg | What is being portrayed in this visual content? | dAux mutations disrupt the proneural enhancement and the lateral inhibition during R8 specification. Projected spinning disk confocal micrographs of Act5C>FLP/+; FRT5-5Z3515, dAuxF956*/FRT5-5Z3515, ubi-GFPnls larval eye stained for Atonal (A-D, red) and Senseless (E-H, red). Regions marked with boxes in (C) and (G) are... |
PMC2391152_F2_23061.jpg | Describe the main subject of this image. | dAux mutations disrupt the proneural enhancement and the lateral inhibition during R8 specification. Projected spinning disk confocal micrographs of Act5C>FLP/+; FRT5-5Z3515, dAuxF956*/FRT5-5Z3515, ubi-GFPnls larval eye stained for Atonal (A-D, red) and Senseless (E-H, red). Regions marked with boxes in (C) and (G) are... |
PMC2391152_F2_23058.jpg | What is the core subject represented in this visual? | dAux mutations disrupt the proneural enhancement and the lateral inhibition during R8 specification. Projected spinning disk confocal micrographs of Act5C>FLP/+; FRT5-5Z3515, dAuxF956*/FRT5-5Z3515, ubi-GFPnls larval eye stained for Atonal (A-D, red) and Senseless (E-H, red). Regions marked with boxes in (C) and (G) are... |
PMC2391152_F2_23063.jpg | What is the main focus of this visual representation? | dAux mutations disrupt the proneural enhancement and the lateral inhibition during R8 specification. Projected spinning disk confocal micrographs of Act5C>FLP/+; FRT5-5Z3515, dAuxF956*/FRT5-5Z3515, ubi-GFPnls larval eye stained for Atonal (A-D, red) and Senseless (E-H, red). Regions marked with boxes in (C) and (G) are... |
PMC2391152_F3_23064.jpg | What can you see in this picture? | dAux mutations disrupt Cut expression at the DV boundary in developing wing discs. Fluorescent micrographs of (A) wild-type and (B-D) Act5C>FLP/+; FRT5-5Z3515, dAuxF956*/FRT5-5Z3515, ubi-GFPnls larval wing discs stained with 2B10 anti-Cut antibody (red). A mutant clone at the DV boundary (indicated by the white box) is... |
PMC2391152_F3_23065.jpg | What does this image primarily show? | dAux mutations disrupt Cut expression at the DV boundary in developing wing discs. Fluorescent micrographs of (A) wild-type and (B-D) Act5C>FLP/+; FRT5-5Z3515, dAuxF956*/FRT5-5Z3515, ubi-GFPnls larval wing discs stained with 2B10 anti-Cut antibody (red). A mutant clone at the DV boundary (indicated by the white box) is... |
PMC2391152_F3_23067.jpg | What is the main focus of this visual representation? | dAux mutations disrupt Cut expression at the DV boundary in developing wing discs. Fluorescent micrographs of (A) wild-type and (B-D) Act5C>FLP/+; FRT5-5Z3515, dAuxF956*/FRT5-5Z3515, ubi-GFPnls larval wing discs stained with 2B10 anti-Cut antibody (red). A mutant clone at the DV boundary (indicated by the white box) is... |
PMC2391166_F1_23069.jpg | What object or scene is depicted here? | a and b. Computed tomography shows the PVTT (white arrow) and bile duct cancer (white dotted arrow). |
PMC2391166_F1_23068.jpg | What is the central feature of this picture? | a and b. Computed tomography shows the PVTT (white arrow) and bile duct cancer (white dotted arrow). |
PMC2394222_fig1_23073.jpg | What is the dominant medical problem in this image? | Growth stimulation of human breast-milk cells by subfragments of EBV DNA from a recombinant cosmid library (Griffin and Karran, 1984), made from a transforming strain of the virus, B95-8. One fragment in particular, p31, has the capacity to rescue epithelial cells in primate biopsies from senescence in culture (Griffin... |
PMC2394222_fig1_23070.jpg | What is the dominant medical problem in this image? | Growth stimulation of human breast-milk cells by subfragments of EBV DNA from a recombinant cosmid library (Griffin and Karran, 1984), made from a transforming strain of the virus, B95-8. One fragment in particular, p31, has the capacity to rescue epithelial cells in primate biopsies from senescence in culture (Griffin... |
PMC2394222_fig1_23071.jpg | What is the dominant medical problem in this image? | Growth stimulation of human breast-milk cells by subfragments of EBV DNA from a recombinant cosmid library (Griffin and Karran, 1984), made from a transforming strain of the virus, B95-8. One fragment in particular, p31, has the capacity to rescue epithelial cells in primate biopsies from senescence in culture (Griffin... |
PMC2394222_fig1_23072.jpg | What is the main focus of this visual representation? | Growth stimulation of human breast-milk cells by subfragments of EBV DNA from a recombinant cosmid library (Griffin and Karran, 1984), made from a transforming strain of the virus, B95-8. One fragment in particular, p31, has the capacity to rescue epithelial cells in primate biopsies from senescence in culture (Griffin... |
PMC2394222_fig1_23074.jpg | Describe the main subject of this image. | Growth stimulation of human breast-milk cells by subfragments of EBV DNA from a recombinant cosmid library (Griffin and Karran, 1984), made from a transforming strain of the virus, B95-8. One fragment in particular, p31, has the capacity to rescue epithelial cells in primate biopsies from senescence in culture (Griffin... |
PMC2394222_fig3_23076.jpg | Describe the main subject of this image. | Histology of variants of EBV-positive ductal carcinoma biopsies (BCs 10, 11 and 12). (Magnification × 200). (A) Panels (at top) show H & E (dark) staining of paraffin-embedded, frozen sections of BC 10, and BC 11. Section were also stained using antibodies CD79a (for B lymphocytes) and CD3 (for T lymphocytes), as noted... |
PMC2394222_fig3_23079.jpg | What is the central feature of this picture? | Histology of variants of EBV-positive ductal carcinoma biopsies (BCs 10, 11 and 12). (Magnification × 200). (A) Panels (at top) show H & E (dark) staining of paraffin-embedded, frozen sections of BC 10, and BC 11. Section were also stained using antibodies CD79a (for B lymphocytes) and CD3 (for T lymphocytes), as noted... |
PMC2394222_fig3_23080.jpg | Can you identify the primary element in this image? | Histology of variants of EBV-positive ductal carcinoma biopsies (BCs 10, 11 and 12). (Magnification × 200). (A) Panels (at top) show H & E (dark) staining of paraffin-embedded, frozen sections of BC 10, and BC 11. Section were also stained using antibodies CD79a (for B lymphocytes) and CD3 (for T lymphocytes), as noted... |
PMC2394222_fig3_23078.jpg | What is the central feature of this picture? | Histology of variants of EBV-positive ductal carcinoma biopsies (BCs 10, 11 and 12). (Magnification × 200). (A) Panels (at top) show H & E (dark) staining of paraffin-embedded, frozen sections of BC 10, and BC 11. Section were also stained using antibodies CD79a (for B lymphocytes) and CD3 (for T lymphocytes), as noted... |
PMC2394222_fig3_23081.jpg | What can you see in this picture? | Histology of variants of EBV-positive ductal carcinoma biopsies (BCs 10, 11 and 12). (Magnification × 200). (A) Panels (at top) show H & E (dark) staining of paraffin-embedded, frozen sections of BC 10, and BC 11. Section were also stained using antibodies CD79a (for B lymphocytes) and CD3 (for T lymphocytes), as noted... |
PMC2394222_fig3_23075.jpg | What key item or scene is captured in this photo? | Histology of variants of EBV-positive ductal carcinoma biopsies (BCs 10, 11 and 12). (Magnification × 200). (A) Panels (at top) show H & E (dark) staining of paraffin-embedded, frozen sections of BC 10, and BC 11. Section were also stained using antibodies CD79a (for B lymphocytes) and CD3 (for T lymphocytes), as noted... |
PMC2394222_fig3_23082.jpg | What does this image primarily show? | Histology of variants of EBV-positive ductal carcinoma biopsies (BCs 10, 11 and 12). (Magnification × 200). (A) Panels (at top) show H & E (dark) staining of paraffin-embedded, frozen sections of BC 10, and BC 11. Section were also stained using antibodies CD79a (for B lymphocytes) and CD3 (for T lymphocytes), as noted... |
PMC2394222_fig3_23077.jpg | What does this image primarily show? | Histology of variants of EBV-positive ductal carcinoma biopsies (BCs 10, 11 and 12). (Magnification × 200). (A) Panels (at top) show H & E (dark) staining of paraffin-embedded, frozen sections of BC 10, and BC 11. Section were also stained using antibodies CD79a (for B lymphocytes) and CD3 (for T lymphocytes), as noted... |
PMC2394227_fig5_23083.jpg | What key item or scene is captured in this photo? | Astocytoma grade II in a patient aged 25 years with a high proliferation (Ki-67) index (A), and frequent nuclei with trisomy for chromosome 7, detected by ISH (B). Counter-staining with DAPI in (B). Magnifications × 800. |
PMC2394254_fig1_23086.jpg | What key item or scene is captured in this photo? | A single CT slice across the abdomen on the left and a single slice from a summed PET H215O image on the right. Areas of increased brightness on the PET scan represent increased perfusion (the whiter the area, the higher the perfusion). There is a large right renal mass representing a primary renal cell carcinoma. This... |
PMC2394260_fig2_23087.jpg | What is being portrayed in this visual content? | Squamous cell carcinoma of a smoker. (A) Loss of Fhit expression (original magnification × 33; ABC method). (B) Overexpression of nuclear staining for p53 (original magnification × 33; ABC method). |
PMC2394260_fig2_23088.jpg | What can you see in this picture? | Squamous cell carcinoma of a smoker. (A) Loss of Fhit expression (original magnification × 33; ABC method). (B) Overexpression of nuclear staining for p53 (original magnification × 33; ABC method). |
PMC2394263_fig1_23089.jpg | What is the dominant medical problem in this image? | Glioma grade II patient transforming to GBM. This MRI shows a patient with grade II glioma, which had transformed to GBM. This is an ongoing response to TMZ and PCB at dose level 3 at 14+ months. |
PMC2394263_fig1_23090.jpg | What can you see in this picture? | Glioma grade II patient transforming to GBM. This MRI shows a patient with grade II glioma, which had transformed to GBM. This is an ongoing response to TMZ and PCB at dose level 3 at 14+ months. |
PMC2394271_fig4_23093.jpg | What's the most prominent thing you notice in this picture? | Immunofluorescence microscopy of neutrophil (in green) adhesion after stimulation with doxorubicin (0.6 μM) with (out) 1 mM monoHER compared to unstimulated HUVECs (in red). |
PMC2394271_fig4_23091.jpg | What is the principal component of this image? | Immunofluorescence microscopy of neutrophil (in green) adhesion after stimulation with doxorubicin (0.6 μM) with (out) 1 mM monoHER compared to unstimulated HUVECs (in red). |
PMC2394271_fig4_23094.jpg | What key item or scene is captured in this photo? | Immunofluorescence microscopy of neutrophil (in green) adhesion after stimulation with doxorubicin (0.6 μM) with (out) 1 mM monoHER compared to unstimulated HUVECs (in red). |
PMC2394271_fig4_23092.jpg | What is the central feature of this picture? | Immunofluorescence microscopy of neutrophil (in green) adhesion after stimulation with doxorubicin (0.6 μM) with (out) 1 mM monoHER compared to unstimulated HUVECs (in red). |
PMC2394302_fig5_23097.jpg | Can you identify the primary element in this image? | Maximum intensity projection PET images of 5-FU treated (165 mg kg−1 i.p.; 48 h postinjection) RIF-1 tumour-bearing C3H/Hej mice injected with (A) 40 μCi of [124I]annexin V or (B) 10 μCi [124I]SIB–annexin V. All time frames from 30 to 60 min (for all coronal planes) were summed to give an indication of retention. With ... |
PMC2394303_fig1_23096.jpg | What object or scene is depicted here? | Human colon adenocarcinomas express FasL. FasL expression on consecutive tumour sections was determined by immunoperoxidase staining, using two different antibodies – (A) rabbit polyclonal (C-20; Santa Cruz Biotechnology) and (B) monoclonal (clone G247-4; PharMingen) FasL-specific antibody. FasL-expressing (brown) tumo... |
PMC2394303_fig2_23112.jpg | What is the dominant medical problem in this image? | Increased apoptosis leading to depletion of TILs in FasL-expressing nests of colonic adenocarcinomas. A–F, FasL-specific immunohistochemical staining (brown) allowed identification of (A) FasL-expressing and (B) FasL-negative tumour nests in close proximity within individual colonic adenocarcinomas. On a consecutive tu... |
PMC2394303_fig2_23110.jpg | What object or scene is depicted here? | Increased apoptosis leading to depletion of TILs in FasL-expressing nests of colonic adenocarcinomas. A–F, FasL-specific immunohistochemical staining (brown) allowed identification of (A) FasL-expressing and (B) FasL-negative tumour nests in close proximity within individual colonic adenocarcinomas. On a consecutive tu... |
PMC2394303_fig2_23111.jpg | What is being portrayed in this visual content? | Increased apoptosis leading to depletion of TILs in FasL-expressing nests of colonic adenocarcinomas. A–F, FasL-specific immunohistochemical staining (brown) allowed identification of (A) FasL-expressing and (B) FasL-negative tumour nests in close proximity within individual colonic adenocarcinomas. On a consecutive tu... |
PMC2394303_fig2_23105.jpg | What is the central feature of this picture? | Increased apoptosis leading to depletion of TILs in FasL-expressing nests of colonic adenocarcinomas. A–F, FasL-specific immunohistochemical staining (brown) allowed identification of (A) FasL-expressing and (B) FasL-negative tumour nests in close proximity within individual colonic adenocarcinomas. On a consecutive tu... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.